Benchling
Implementation Manager - Bilingual
Zurich, Switzerland, Remote. Posted 3 days ago
The role
You will lead the rollout of the Benchling platform for customers, from kickoff to go-live. You will work with customer scientists to understand their R&D workflows, configure the system, and train users.
What you will do
- Manage initial rollouts for new Benchling customers and expansion projects at existing customers
- Own implementation success from project kickoff to go-live
- Build and execute detailed project plans, on time, on budget, high quality
- Understand customers' scientific workflows and how Benchling can meet their needs
- Lead requirements and design workshops, data modeling and application configuration
- Develop test plans, guide UAT execution, train and onboard users
- Act as a trusted advisor, guiding customers to Benchling Best Practices
- Document customer pain points and advocate for them internally to influence product changes
- Identify account expansion opportunities with sales after go-live
Required qualifications
- MS or Ph.D. in Molecular Biology, Biochemistry, Biotechnology, Immunology, Bioinformatics, Biological Engineering or a related field
- At least 2 years of experience in a lab or R&D setting
- Software implementation experience, preferably with a SaaS company
- Strong communication skills with scientists, IT project leads and executives
- Self-starter able to succeed in a startup environment
- Curious, creative and tenacious
- Ability to travel up to 25%
- Fluent or native proficiency in French or German
- Ability to empathize with scientists and quickly understand complex scientific concepts
Nice to have
- Experience using Benchling, especially as a Benchling administrator
Before you apply
- Fluent or native French or German is required for this role
- Interview process includes a brief AI-focused exercise or discussion
About the company
Benchling is the AI platform for biotech R&D, used by over 200,000 scientists worldwide. Its customers include Sanofi, Moderna and more than half of the world's top 50 biopharma companies.